Centogene N.V.
NASDAQ: CNTG0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Kim Stratton
- Employees
- 384
- Headquarters
- Rostock, Germany
- IPO year
- 2019
- Market cap
- $9.4M
- Website
- https://www.centogene.com
Loading CNTG…
Loading profile data…Frequently asked questions about CNTG
What does Centogene N.V. (CNTG) do?
Centogene N.V., along with its affiliates, operates globally with a primary focus on rare diseases. The company excels at converting diverse real-world data—spanning clinical, genetic, and other sources—into practical insights for patients, medical professionals, and pharmaceutical enterprises worldwide. Its activities are organized across three...
Where does CNTG trade?
Centogene N.V. (CNTG) trades on the NASDAQ Global Market.
What sector is CNTG in?
Centogene N.V. (CNTG) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Centogene N.V.?
Kim Stratton is the chief executive officer of Centogene N.V. (CNTG).
Where is Centogene N.V. headquartered?
Centogene N.V. is headquartered in Germany.
Does CNTG pay a dividend?
Centogene N.V. (CNTG) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CNTG go public?
Centogene N.V. (CNTG) completed its initial public offering in 2019.